Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patients with Multiple Myeloma and Kidney Failure on Maintenance Hemodialysis: A Report of 2 Cases

Chimeric antigen receptor (CAR) T-cell therapy against B-cell maturation antigen is a new treatment modality for relapsed or refractory multiple myeloma (MM). Patients with kidney failure and MM were excluded from the pivotal CAR T-cell therapy clinical trials: KaRMMa (idecabtagene vicleucel) and CA...

Full description

Bibliographic Details

Published in:	Kidney Medicine
Main Authors:	Wai Lun Will Pak, Natalie A. Brumwell, Charlene C. Kabel, Victoria Gutgarts, Insara Jaffer Sathick, Sham Mailankody, Alexander M. Lesokhin, Heather J. Landau, Aisha Shaikh
Format:	Article
Language:	English
Published:	Elsevier 2024-08-01
Subjects:	Cellular therapy multiple myeloma end-stage kidney disease hemodialysis neurotoxicity lymphodepletion
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590059524000670